馬偕醫學大學機構典藏(MacKay Medical University Institutional Repository):Item 987654321/2787
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 1657/1756
造访人次 : 3733792      在线人数 : 162
RC Version 5.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 进阶搜寻

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://140.112.115.32:8080/ir/handle/987654321/2787

题名: A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI
作者: Shih, Tzenge-Lien;Lin, Kuan-Hung;Chen, Ray-Jade;Chen, Ting-Yu;Kao, Wei-Ting;Liu, Jen-Wei;Wang, Hsueh-Hsiao;Peng, Hsien-Yu;Sun, Yu-Yo;Lu, Wan-Jung
贡献者: 視光學系
日期: 2021-10-01
上传时间: 2025-08-11 14:43:50 (UTC+8)
摘要: Naphthalimide derivatives have multiple biological activities, including antitumour and anti-inflammatory activities. We previously synthesized several naphthalimide derivatives; of them, compound 5 was found to exert the strongest inhibitory effect on human DNA topoisomerase II activity. However, the effects of naphthalimide derivatives on platelet activation have not yet been investigated. Therefore, the mechanism underlying the antiplatelet activity of compound 5 was determined in this study. The data revealed that compound 5 (5–10 μM) inhibited collagen- and convulxin- but not thrombin- or U46619-mediated platelet aggregation, suggesting that compound 5 is more sensitive to the inhibition of glycoprotein VI (GPVI) signalling. Indeed, compound 5 could inhibit the phosphorylation of signalling molecules downstream of GPVI, followed by the inhibition of calcium mobilization, granule release and GPIIb/IIIa activation. Moreover, compound 5 prevented pulmonary embolism and prolonged the occlusion time, but tended to prolong the bleeding time, indicating that it can prevent thrombus formation but may increase bleeding risk. This study is the first to demonstrate that the naphthalimide derivative compound 5 exerts antiplatelet and antithrombotic effects. Future studies should modify compound 5 to synthesize more potent and efficient antiplatelet agents while minimizing bleeding risk, which may offer a therapeutic potential for cardiovascular diseases.
關聯: Journal of Cellular and Molecular Medicine, 25(19), 9434-9446. https://doi.org/https://doi.org/10.1111/jcmm.16886
显示于类别:[視光學系] 期刊論文

文件中的档案:

档案 大小格式浏览次数
index.html0KbHTML2检视/开启


在MMUIR中所有的数据项都受到原著作权保护.

 


DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈